{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:23:45Z","timestamp":1715599425844},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hypertens Rep"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1007\/s11906-017-0715-4","type":"journal-article","created":{"date-parts":[[2017,2,23]],"date-time":"2017-02-23T08:27:13Z","timestamp":1487838433000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Ambiguities in the Guidelines for the Management of Arterial Hypertension: Indian Perspective with a Call for Global Harmonization"],"prefix":"10.1007","volume":"19","author":[{"given":"Harmeet Singh","family":"Rehan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhinav","family":"Grover","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A. P. S.","family":"Hungin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,23]]},"reference":[{"key":"715_CR1","first-page":"745","volume-title":"The pharmacological basis of therapeutics","author":"T Michel","year":"2011","unstructured":"Michel T, Hoffman BB. Treatment of myocardial ischemia and hypertension. In: Brunton LL, Chabner BA, Knollman BC, editors. The pharmacological basis of therapeutics. 12th ed. New York: McGraw-Hill Medical; 2011. p. 745\u201388.","edition":"12"},{"issue":"9438","key":"715_CR2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/S0140-6736(04)17018-9","volume":"364","author":"S Yusuf","year":"2004","unstructured":"Yusuf S, Hawken S, Ounpuu S, Dans T, Avezum A, Lanas F. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case\u2013control study. Lancet. 2004;364(9438):937\u201352.","journal-title":"Lancet"},{"issue":"19","key":"715_CR3","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","volume":"289","author":"AV Chobanian","year":"2003","unstructured":"Chobanian AV, Barkis GL, Black HR, et al. The seventh report of the Joint National Committee on prevention, detection, evaluation and treatment of high blood pressure. The JNC seventh report. JAMA. 2003;289(19):2560\u201371.","journal-title":"JAMA"},{"issue":"5","key":"715_CR4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1097\/HJH.0b013e32835f7eef","volume":"31","author":"J Chalmers","year":"2013","unstructured":"Chalmers J, Arima H, Harrap S, et al. Global survey of current practice in management of hypertension as reported by societies affiliated with the International Society of Hypertension. J Hypertens. 2013;31(5):1043\u20138.","journal-title":"J Hypertens"},{"issue":"2 Suppl","key":"715_CR5","first-page":"6","volume":"61","author":"Association of Physicians of India","year":"2013","unstructured":"Association of Physicians of India. Indian guidelines on hypertension (I.G.H.)\u2014III. 2013. J Assoc Physicians India. 2013;61(2 Suppl):6\u201336.","journal-title":"J Assoc Physicians India"},{"key":"715_CR6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1093\/eurheartj\/eht151","volume":"34","author":"G Mancia","year":"2013","unstructured":"Mancia G, Fagard R, Narkiewicz K, et al. 2013 ESH\/ESC guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). Eur Heart J. 2013;34:2159\u2013219.","journal-title":"Eur Heart J"},{"issue":"1","key":"715_CR7","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1007\/s40292-014-0038-3","volume":"21","author":"A Virdis","year":"2014","unstructured":"Virdis A, Ghiadoni L, Taddei S. Clinical management of drug-induced hypertension: 2013 Practical Recommendations of the Italian Society of Hypertension (SIIA). High Blood Press Cardiovasc Prev. 2014;21(1):77\u20139. doi: 10.1007\/s40292-014-0038-3 .","journal-title":"High Blood Press Cardiovasc Prev"},{"issue":"10","key":"715_CR8","first-page":"785","volume":"58","author":"J Filipovsk\u00fd","year":"2012","unstructured":"Filipovsk\u00fd J, Widimsk\u00fd Jr J, Ceral J, et al. Diagnosis and treatment of arterial hypertension. 2012 Guidelines of the Czech Hypertension Society. Vnitr Lek. 2012;58(10):785\u2013801.","journal-title":"Vnitr Lek"},{"issue":"3","key":"715_CR9","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1016\/j.ancard.2013.04.009","volume":"62","author":"J Blacher","year":"2013","unstructured":"Blacher J, Halimi JM, Hanon O, et al. Management of arterial hypertension in adults: 2013 guidelines of the French Society of Arterial Hypertension. Ann Cardiol Angeiol. 2013;62(3):132\u20138. doi: 10.1016\/j.ancard.2013.04.009 .","journal-title":"Ann Cardiol Angeiol"},{"key":"715_CR10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","volume":"311","author":"PA James","year":"2014","unstructured":"James PA, Oparil S, Carter BL, et al. 2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8). JAMA. 2014;311:507\u201320.","journal-title":"JAMA"},{"issue":"4","key":"715_CR11","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/hr.2014.20","volume":"37","author":"K Shimamoto","year":"2014","unstructured":"Shimamoto K, Ando K, Fukita T, et al. The Japanese society of hypertension guidelines for the management of hypertension (JSH 2014). Hypertens Res. 2014;37(4):253\u2013387.","journal-title":"Hypertens Res"},{"key":"715_CR12","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1016\/j.cjca.2014.02.002","volume":"30","author":"K Dasgupta","year":"2014","unstructured":"Dasgupta K, Quinn RR, Zarnke KB, et al. The 2014 Canadian Hypertension Education Program (CHEP) recommendations for blood pressure measurement, diagnosis, assessment of risk, prevention and treatment of hypertension. Can J Cardiol. 2014;30:485\u2013501.","journal-title":"Can J Cardiol"},{"key":"715_CR13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000000065","volume":"32","author":"MA Weber","year":"2014","unstructured":"Weber MA, Schiffrin EL, White WB, et al. Clinical practice guidelines for the management of hypertension in the community a statement by the American Society of Hypertension and the International Society of Hypertension. J Hypertens. 2014;32:3\u201315.","journal-title":"J Hypertens"},{"key":"715_CR14","unstructured":"National Institute for Health and Care Excellence. Hypertension: clinical management of primary hypertension in adults (Clinical guideline 127). http:\/\/guidance.nice.org.uk\/CG127 . Accessed 10 July 2016."},{"key":"715_CR15","unstructured":"World Health Organisation. A global brief on hypertension: silent killer, global public health crisis. 2013. http:\/\/apps.who.int\/iris\/bitstream\/10665\/79059\/1\/WHO_DCO_WHD_2013.2_eng.pdf?ua=1 . Accessed 10 July 2016."},{"issue":"12","key":"715_CR16","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1291\/hypres.31.2115","volume":"31","author":"JATOS Study Group","year":"2008","unstructured":"JATOS Study Group. Principal results of the Japanese trial to assess optimal systolic blood pressure in elderly hypertensive patients (JATOS). Hypertens Res. 2008;31(12):2115\u201327.","journal-title":"Hypertens Res"},{"issue":"2","key":"715_CR17","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1161\/HYPERTENSIONAHA.109.146035","volume":"56","author":"T Ogihara","year":"2010","unstructured":"Ogihara T, Saruta T, Rakugi H, et al. Valsartan in Elderly Isolated Systolic Hypertension Study Group. Target blood pressure for treatment of isolated systolic hypertension in the elderly: Valsartan in Elderly Isolated Systolic Hypertension Study. Hypertension. 2010;56(2):196\u2013202.","journal-title":"Hypertension"},{"key":"715_CR18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.7326\/0003-4819-126-10-199705150-00002","volume":"126","author":"F Gueyffier","year":"1997","unstructured":"Gueyffier F, Boutitie F, Boisset JP, et al. Effect of antihypertensive drug treatment on cardiovascular outcomes in women and men. A meta-analysis of individual patient data from randomized, controlled trials. The INDANA Investigators. Ann Intern Med. 1997;126:761\u20137.","journal-title":"Ann Intern Med"},{"key":"715_CR19","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/0140-6736(90)90944-Z","volume":"335","author":"R Collins","year":"1990","unstructured":"Collins R, Peto R, MacMahon S, et al. Blood pressure, stroke, and coronary heart disease. Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context. Lancet. 1990;335:827\u201338.","journal-title":"Lancet"},{"key":"715_CR20","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(14)61212-5","volume":"384","author":"Blood Pressure Lowering Treatment Trialists Collaboration","year":"2014","unstructured":"Blood Pressure Lowering Treatment Trialists Collaboration. Blood pressure-lowering treatment based on cardiovascular risk: a meta-analysis of individual patient data. Lancet. 2014;384:591\u20138.","journal-title":"Lancet"},{"key":"715_CR21","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1016\/S0140-6736(00)03307-9","volume":"356","author":"B Neal","year":"2000","unstructured":"Neal B, MacMahon S, Chapman N, for the Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists\u2019 Collaboration. Lancet. 2000;356:1955\u201364.","journal-title":"Lancet"},{"issue":"10017","key":"715_CR22","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1016\/S0140-6736(15)00805-3","volume":"387","author":"X Xie","year":"2016","unstructured":"Xie X, Atkins E, Lv J, et al. Effects of intensive blood pressure lowering on cardiovascular and renal outcomes: updated systematic review and meta-analysis. Lancet. 2016;387(10017):435\u201343. doi: 10.1016\/S0140-6736(15)00805-3 .","journal-title":"Lancet"},{"issue":"21","key":"715_CR23","doi-asserted-by":"publisher","first-page":"2009","DOI":"10.1056\/NEJMoa1600175","volume":"374","author":"EM Lonn","year":"2016","unstructured":"Lonn EM, Bosch J, L\u00f3pez-Jaramillo P, et al. Blood-pressure lowering in intermediate-risk persons without cardiovascular disease. N Engl J Med. 2016;374(21):2009\u201320. doi: 10.1056\/NEJMoa1600175 .","journal-title":"N Engl J Med"},{"issue":"23","key":"715_CR24","doi-asserted-by":"crossref","first-page":"2981","DOI":"10.1001\/jama.288.23.2981","volume":"288","author":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group","year":"2002","unstructured":"ALLHAT Officers and Coordinators for the ALLHAT Collaborative Research Group. The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial: major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic. JAMA. 2002;288(23):2981\u201397.","journal-title":"JAMA"},{"issue":"3","key":"715_CR25","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1007\/s11739-016-1422-x","volume":"11","author":"LM Brewster","year":"2016","unstructured":"Brewster LM, van Montfrans GA, Oehlers GP, et al. Systematic review: antihypertensive drug therapy in patients of African and South Asian ethnicity. Intern Emerg Med. 2016;11(3):355\u201374. doi: 10.1007\/s11739-016-1422-x .","journal-title":"Intern Emerg Med"},{"key":"715_CR26","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/1741-7015-11-141","volume":"11","author":"LM Brewster","year":"2013","unstructured":"Brewster LM, Seedat YK. Why do hypertensive patients of African ancestry respond better to calcium blockers and diuretics than to ACE inhibitors and b-adrenergic blockers? A systematic review. BMC Med. 2013;11:141.","journal-title":"BMC Med"},{"key":"715_CR27","doi-asserted-by":"crossref","first-page":"614","DOI":"10.7326\/0003-4819-141-8-200410190-00009","volume":"141","author":"LM Brewster","year":"2004","unstructured":"Brewster LM, van Montfrans GA, Kleijnen J. Systematic review: antihypertensive drug therapy in black patients. Ann Intern Med. 2004;141:614\u201327.","journal-title":"Ann Intern Med"},{"key":"715_CR28","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJM200001203420301","volume":"342","author":"The Heart Outcomes Prevention Evaluation Study Investigators","year":"2000","unstructured":"The Heart Outcomes Prevention Evaluation Study Investigators. Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high risk patients. N Engl Med. 2000;342:145\u201353.","journal-title":"N Engl Med"},{"key":"715_CR29","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa0801317","volume":"358","author":"The ONTARGET investigators","year":"2008","unstructured":"The ONTARGET investigators. Telmisartan, ramipril or both in patients at high risk for vascular events. NEJM. 2008;358:1547\u201359.","journal-title":"NEJM"},{"key":"715_CR30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(05)67185-1","volume":"366","author":"B Dahl\u00f6f","year":"2005","unstructured":"Dahl\u00f6f B, Sever PS, Poulter NR, Wedel H, Beevers DG, Caulfield M, et al. Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as requiredversus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm (ASCOT-BPLA): a multicentre randomised controlled trial. Lancet. 2005;366:895\u2013906.","journal-title":"Lancet"},{"key":"715_CR31","doi-asserted-by":"crossref","first-page":"c6624","DOI":"10.1136\/bmj.c6624","volume":"341","author":"J Hippisley-Cox","year":"2010","unstructured":"Hippisley-Cox J, Coupland C, Robson J, Brindle P. Derivation, validation, and evaluation of a new QRISK model to estimate lifetime risk of cardiovascular disease: cohort study using QResearch database. BMJ. 2010;341:c6624.","journal-title":"BMJ"},{"key":"715_CR32","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1136\/hrt.2006.092346","volume":"92","author":"P Brindle","year":"2006","unstructured":"Brindle P, May M, Gill P, Cappuccio F, D\u2019Agostino Sr R, Fischbacher C, et al. Primary prevention of cardiovascular disease: a web-based risk score for seven British black and minority ethnic groups. Heart. 2006;92:1595\u2013602.","journal-title":"Heart"}],"container-title":["Current Hypertension Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-017-0715-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11906-017-0715-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11906-017-0715-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,25]],"date-time":"2017-06-25T11:11:18Z","timestamp":1498389078000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11906-017-0715-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["715"],"URL":"https:\/\/doi.org\/10.1007\/s11906-017-0715-4","relation":{},"ISSN":["1522-6417","1534-3111"],"issn-type":[{"value":"1522-6417","type":"print"},{"value":"1534-3111","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2]]},"article-number":"17"}}